ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX)

CUSIP: 45256X103

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
1,124,549,707
Total 13F shares
68,558,924
Share change
+6,579,019
Total reported value
$255,147,599
Put/Call ratio
78%
Price per share
$3.72
Number of holders
172
Value change
+$21,750,911
Number of buys
81
Number of sells
68

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 45256X103?
CUSIP 45256X103 identifies IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
1.2%
13,831,796
$87,416,951 30 Jun 2024
13F
BlackRock Finance, Inc.
13F
Company
1%
11,423,089
$72,193,924 30 Jun 2024
13F
STATE STREET CORP
13F
Company
0.7%
7,864,052
$49,700,809 30 Jun 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.35%
3,917,494
$24,763,179 30 Jun 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.15%
1,716,059
$10,845,493 30 Jun 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.14%
1,577,827
$9,971,866 30 Jun 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.11%
1,236,316
$7,813,517 30 Jun 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.11%
1,183,416
$7,479,190 30 Jun 2024
13F
NORTHERN TRUST CORP
13F
Company
0.1%
1,141,762
$7,215,936 30 Jun 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.09%
1,024,975
$6,477,842 30 Jun 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.09%
958,527
$6,057,890 30 Jun 2024
13F
FIRST TRUST ADVISORS LP
13F
Company
0.08%
887,620
$5,609,758 30 Jun 2024
13F
ALLEN HOLDING INC /NY
13F
Company
0.06%
687,571
$4,345,449 30 Jun 2024
13F
SHEETS SMITH WEALTH MANAGEMENT
13F
Company
0.06%
665,995
$4,209,088 30 Jun 2024
13F
Bank of New York Mellon Corp
13F
Company
0.06%
621,536
$3,928,110 30 Jun 2024
13F
MORGAN STANLEY
13F
Company
0.05%
568,401
$3,592,294 30 Jun 2024
13F
Accurate Wealth Management, LLC
13F
Company
0.05%
560,000
$3,561,600 30 Jun 2024
13F
Clearwater Capital Advisors, LLC
13F
Company
0.04%
482,549
$3,049,710 30 Jun 2024
13F
ROYAL BANK OF CANADA
13F
Company
0.04%
470,194
$2,972,000 30 Jun 2024
13F
UBS Group AG
13F
Company
0.04%
458,255
$2,896,172 30 Jun 2024
13F
Woodline Partners LP
13F
Company
0.04%
437,843
$2,767,168 30 Jun 2024
13F
Rafferty Asset Management, LLC
13F
Company
0.04%
435,653
$2,753,327 30 Jun 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.04%
403,528
$2,550,297 30 Jun 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.03%
379,101
$2,395,918 30 Jun 2024
13F
HARBOURVEST PARTNERS LLC
13F
Company
0.03%
335,709
$2,121,681 30 Jun 2024
13F
Skandinaviska Enskilda Banken AB (publ)
13F
Company
0.02%
270,950
$1,712,404 30 Jun 2024
13F
Swiss National Bank
13F
Company
0.02%
263,100
$1,662,792 30 Jun 2024
13F
NATIONAL BANK OF CANADA /FI/
13F
Company
0.02%
263,300
$1,650,891 30 Jun 2024
13F
Corient Private Wealth LLC
13F
Company
0.02%
222,080
$1,403,545 30 Jun 2024
13F
Marex Group plc
13F
Company
0.02%
218,900
$1,383,448 30 Jun 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.02%
216,978
$1,371,301 30 Jun 2024
13F
RHUMBLINE ADVISERS
13F
Company
0.02%
211,677
$1,337,785 30 Jun 2024
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.02%
207,196
$1,309,479 30 Jun 2024
13F
BLAIR WILLIAM & CO/IL
13F
Company
0.02%
206,800
$1,306,976 30 Jun 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.02%
205,530
$1,298,950 30 Jun 2024
13F
COWEN AND COMPANY, LLC
13F
Company
0.02%
200,000
$1,264,000 30 Jun 2024
13F
FRANKLIN RESOURCES INC
13F
Company
0.02%
199,181
$1,258,824 30 Jun 2024
13F
Deutsche Girozentrale DekaBank
13F
Individual
0.02%
196,200
$1,234,000 30 Jun 2024
13F
Clearstead Advisors, LLC
13F
Company
0.02%
188,500
$1,191,320 30 Jun 2024
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.02%
180,450
$1,140,444 30 Jun 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.02%
179,141
$1,132,171 30 Jun 2024
13F
John C. Thomas
3/4/5
Former Director
class O/S missing
216,363
$1,086,143 31 Dec 2021
BARCLAYS PLC
13F
Company
0.01%
158,788
$1,003,540 30 Jun 2024
13F
Erste Asset Management GmbH
13F
Company
0.01%
153,000
$1,000,620 30 Jun 2024
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.01%
132,212
$835,580 30 Jun 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.01%
130,761
$828,000 30 Jun 2024
13F
Legal & General Group Plc
13F
Company
0.01%
130,900
$827,288 30 Jun 2024
13F
READYSTATE ASSET MANAGEMENT LP
13F
Company
0.01%
124,885
$789,273 30 Jun 2024
13F
Sculptor Capital LP
13F
Company
0.01%
122,500
$774,200 30 Jun 2024
13F
LPL Financial LLC
13F
Company
0.01%
120,402
$760,941 30 Jun 2024
13F

Institutional Holders of ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) as of Q3 2024

As of 30 Sep 2024, ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) was held by 172 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 68,558,924 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, GOLDMAN SACHS GROUP INC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and NORTHERN TRUST CORP. This page lists 172 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
188
Q3 2024 holders
172
Holder diff
-16
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 Value $ Q3 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.